[124 Pages Report] The transfer membrane market is projected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period.

Years considered for the study

Base Year-2017

Estimated Year-2018

Forecast Period-2018-2023

Objectives of the study are:

To define, describe, and forecast the market by type, transfer method, application, end user, and region

To provide detailed information regarding the major factors influencing market growth (drivers, restraints, and opportunities) along with the current trends

To strategically analyze micromarkets with respect to their individual growth trends, prospects, and contributions to the total market

To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

To forecast the revenue of the market segments in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa

To profile the key players and comprehensively analyze their market shares and core competencies

To track and analyze competitive developments such as acquisitions and expansions in the market

Research Methodology

This research study involved the usage of extensive secondary sources, directories, and databases such as D&B, Bloomberg Business, and Factiva, along with government databases, to identify and collect information useful for this technology-based, market-oriented, and commercial study of the transfer membrane market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects.

The secondary sources referred to for this research study include corporate filings (such as annual reports, SEC filings, investor presentations, and financial statements); research journals; press releases; as well as articles published by various Bioinformatics service providers, and professional associations.

To know about the assumptions considered for the study, download the pdf brochure

Merck KGaA (US), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), GE Healthcare (US), PerkinElmer (US), Pall Coporation (US), Advansta (US), GVS (Italy), Santa Cruz Biotechnology (US), Abcam (UK), ATTO Corporation (Japan), Carl Roth (Germany), Macherey-Nagel (Germany), Azure Biosystems (US), and Axiva Sichem Biotech (India), , are some of the key players in the global market. Some of the leading players in the market adopt inorganic growth strategies such as acquisitions to enhance its market position.

Stakeholders

Transfer membrane manufacturers

Transfer membrane suppliers and distributors

Research laboratories and academic institutes

Government & non-government laboratories

Venture capitalists and other funding organizations

Healthcare institutions (hospitals and diagnostic clinics)

Pharmaceutical and biotechnology companies

Forensic laboratories

Contract research organizations

Scope of the Report

This research report categorizes the transfer membrane market into the following segments and subsegments:

Transfer Membrane Market, By Type

PVDF

Nitrocellulose

Nylon

Transfer Membrane Market, By Transfer Method

Tank Electrotransfer

Semi-dry Electrotransfer

Dry Electrotransfer

Other Transfer Methods

Transfer Membrane Market, By Application

Western Blotting

Northern Blotting

Southern Blotting

Protein Sequencing and Amino Acid Analysis

Others Applications

Transfer Membrane Market, By End User

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Diagnostic Laboratories

Other End Users

Transfer Membrane Market, By Region

North America US Canada

Europe Germany France UK Rest of Europe

Asia Pacific China India Japan Rest of APAC

Rest of the World Middle East and Africa Latin America



*Note: Other applications include colony/plaque lift and dot/slot blots.

Other transfer methods include diffusion blotting and vacuum blotting.

Other end users include contract research organizations, blotting service providers, food & beverage companies, and forensic laboratories.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company�s specific needs. The following customization options are available for the report:

Product Analysis

Product matrix which gives a detailed comparison of the product portfolios of the top five companies

Company Information

Detailed analysis and profiling of additional market players (up to 5)

The global transfer membrane market is expected to reach USD 187.9 million by 2023 from USD 174.8 million in 2018, at a CAGR of 1.5% during the forecast period. Factors such as increasing public and private funding for life science research, the significantly high prevalence of target diseases across the globe, and increasing R&D spending by pharmaceutical and biotechnology companies are expected to drive the growth of market.

The report analyzes the global market by type, transfer method, application, end user, and region.

On the basis of type, the market is divided into nylon membranes, nitrocellulose membranes, and PVDF membranes. In 2018, PVDF Membranes are expected to command for the major share of the market. This can be attributed to the advantages of PVDF membranes over its counterparts, such as better protein retention, strength, chemical compatibility, and wide applications in western blotting.

Based on end user, the market is segmented into academic and research institutes, pharmaceutical and biotechnology companies, diagnostic laboratories, and other end users. Among these, the academic and research institutes segment is expected to account for the largest share of the transfer membrane market in 2018, owing it to the rising financial support from private as well as government bodies for life science research in various nations.

This report covers the market data across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the global transfer membrane market in 2018, followed by Europe. The large share in the North American region is mainly attributed to the presence of leading transfer membrane manufacturers in the region, availability of government and private financial support for life science research, and high target disease prevalence in the region. Factors such as rising proteomic research and growing scale of life science projects funded by government and private bodies, are driving the growth of the Asia Pacific market.

The the availability of alternative technologies and the need of skilled professionals are expected to restrain the growth of the market in the forecast period.

As of 2017, Merck KGaA (US) dominates the global transfer membrane market through its broad product portfolio, strong geographical presence, and wide customer base across the globe. Thermo Fisher Scientific (US) held the second leadership position in the global market. Other prominent players in the global market included PerkinElmer (US), , Bio-Rad Laboratories (US), GE Healthcare (US), Pall Coporation (US), Advansta (US), GVS (Italy), Santa Cruz Biotechnology (US), Abcam (UK), ATTO Corporation (Japan), Carl Roth (Germany), Macherey-Nagel (Germany), Azure Biosystems (US), and Axiva Sichem Biotech (India),.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst